Table 2

Patient demographical characteristics of 68 multiple primary patients with hepatocellular carcinoma
Characteristic Total Synchronous group (n = 22) Metachronous group (n = 46) P value *
Age (years)
  < 58 b 33 8 25 0.165
  ≥ 58 35 14 21
Gender 0.514
  Male 61 21 40
  Female 7 1 6
HBsAg status 0.393
  Negative 23 9 14
  Positive 45 13 32
Serum AFP level (ng/ml) 0.085
  < 25 30 13 17
  ≥ 25 38 9 29
Serum GGT level (U/ml) 0.181
  < 50 23 5 18
  ≥ 50 45 17 28
Child-Pugh classification 0.932
  A 49 16 33
  B 19 6 13
TNM stage 0.735
  I 43 14 29
  II 9 2 7
  III 16 6 10
Treatment for HCC 0.309
  Resection 35 9 26
  Ablation 7 3 4
  TACE 14 4 10
  Supportive 11 6 5
Treatment for extrahepatic cancer <0.001
  Curative 54 12 42
  Palliative 8 4 4
  Supportive 6 6 0

HCC hepatocellular carcinoma, HbsAg Hepatitis B surface Antigen, AFP α-fetoprotein, GGT gamma-glutamyltransferase, TNM tumor-node-metastasis, TACE transarterial chemoembolization.

* Chi-square or Fisher’s exact test.

Patients were divided according to the median age.

Zeng et al.

Zeng et al. BMC Cancer 2012 12:148   doi:10.1186/1471-2407-12-148

Open Data